Brief: China Biotech Services Sees Net Profit Of Not Less Than HK$140 Mln For 2020
01/03/2021 10:29
March 1 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* SEES NET PROFIT OF NOT LESS THAN HK$140 MILLION FOR 2020
* EXPECTED RESULT DUE TO INCREASE IN DEMAND FOR COVID-19
TESTING
SERVICES
Source text for Eikon: ID:nHKS4j4Rn7
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)